Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 1;1(3):270-301.
doi: 10.1002/mco2.26. eCollection 2020 Dec.

Coronavirus in human diseases: Mechanisms and advances in clinical treatment

Panpan Lin  1 , Manni Wang  1 , Yuquan Wei  1 , Taewan Kim  2 , Xiawei Wei  1
Affiliations
Review

Coronavirus in human diseases: Mechanisms and advances in clinical treatment

Panpan Lin et al. MedComm (2020). .

Abstract

Coronaviruses (CoVs), a subfamily of coronavirinae, are a panel of single-stranded RNA virus. Human coronavirus (HCoV) strains (HCoV-229E, HCoV-OC43, HCoV-HKU1, HCoV-NL63) usually cause mild upper respiratory diseases and are believed to be harmless. However, other HCoVs, associated with severe acute respiratory syndrome, Middle East respiratory syndrome, and COVID-19, have been identified as important pathogens due to their potent infectivity and lethality worldwide. Moreover, currently, no effective antiviral drugs treatments are available so far. In this review, we summarize the biological characters of HCoVs, their association with human diseases, and current therapeutic options for the three severe HCoVs. We also highlight the discussion about novel treatment strategies for HCoVs infections.

Keywords: COVID‐19; MERS; SARS; clinical treatments; human coronaviruses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Genome organization and structure of HCoVs
FIGURE 2
FIGURE 2
Escape mechanisms of innate immune response of SARS‐CoV and MERS‐CoV
FIGURE 3
FIGURE 3
Mechanisms of current anti‐CoV therapeutic agents
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Woo PCY, Lau SKP, Huang Y, Yuen K‐Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood). 2009;234:1117‐1127. - PubMed
    1. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85‐164. - PMC - PubMed
    1. Chan JFW, Li KSM, To KKW, Cheng VCC, Chen H, Yuen K‐Y. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV‐EMC) the beginning of another SARS‐like pandemic? J Infect. 2012;65:477‐489. - PMC - PubMed
    1. Woo PCY, Lau SKP, Lam CSF, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86:3995‐4008. - PMC - PubMed
    1. Chan JF‐W, To KK‐W, Tse H, Jin D‐Y, Yuen K‐Y. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013;21:544‐555. - PMC - PubMed